+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Enzymatic DNA Synthesis Market by Technology, Component, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6015372
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Enzymatic DNA Synthesis Market grew from USD 4.87 billion in 2023 to USD 5.37 billion in 2024. It is expected to continue growing at a CAGR of 10.51%, reaching USD 9.82 billion by 2030.

Enzymatic DNA synthesis refers to the method of using enzymes to synthesize DNA sequences, representing a pivotal advancement in biotechnology and genomics. This technique is necessary for rapid and efficient creation of DNA sequences, vital for research in genomics, pharmaceutical development, and synthetic biology. Its applications span across gene synthesis, diagnostic tools, personalized medicine, and biosensors, with end-use sectors including biotechnology firms, academic research institutions, pharmaceutical companies, and clinical laboratories. The market is primarily driven by an increasing demand for DNA-based therapeutics and vaccines, advancements in personalized medicine, and growing interest in synthetic biology as a tool for tackling complex biological challenges. Additionally, rising research and development investments to enhance enzymatic processes for cost-effectiveness and speed underpin market growth. However, challenges such as high initial investment costs, the complexity of the enzymatic synthesis process, limited efficiency in producing longer DNA sequences, and competition from traditional chemical synthesis methods may hinder progress. Potential opportunities lie in leveraging artificial intelligence and machine learning to optimize DNA sequence design and synthesis, which could considerably expand the accuracy and scope of enzymatic synthesis. Companies could benefit from collaborative ventures with research institutions to foster innovation and expand application areas. Emphasizing customization and flexibility in DNA production processes to cater to specific client needs would also open new avenues for business growth. The enzymatic DNA synthesis market is currently evolving, with an increasing focus on sustainable and scalable processes that align with future biotechnological techniques, suggesting a shift towards more environmentally friendly and efficient methodologies. Innovations in these areas could enhance capabilities, ensuring more extensive adoption and integration into multiple fields, thus, fostering expanded market potential.

Understanding Market Dynamics in the Enzymatic DNA Synthesis Market

The Enzymatic DNA Synthesis Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Adoption of synthetic DNA in diagnostics and personalized medicine for better patient outcomes
    • Expansion of genomic data and need for rapid DNA synthesis in research and clinical settings
    • Strategic collaborations between key players to accelerate the development of innovative DNA synthesis solutions
    • Cost-effectiveness and scalability of enzymatic DNA synthesis compared to traditional methods
  • Market Restraints
    • Complexity and technical challenges in ensuring the precision and accuracy of enzymatic DNA synthesis leading to potential errors and inefficiencies
    • High costs associated with research and development in enzymatic DNA synthesis technology limiting accessibility and affordability
  • Market Opportunities
    • Increasing adoption of enzymatic DNA synthesis by pharmaceutical companies for drug development and screening
    • Innovative enzymatic DNA synthesis solutions enabling rapid prototyping of DNA constructs for synthetic biology
    • High-throughput enzymatic DNA synthesis technologies supporting large-scale production of custom DNA sequences
  • Market Challenges
    • Regulatory hurdles and compliance issues associated with enzymatic DNA synthesis technologies
    • Competition from established DNA synthesis technologies limits market penetration of enzymatic DNA synthesis

Exploring Porter’s Five Forces for the Enzymatic DNA Synthesis Market

Porter’s Five Forces framework further strengthens the insights of the Enzymatic DNA Synthesis Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Enzymatic DNA Synthesis Market

External macro-environmental factors deeply influence the performance of the Enzymatic DNA Synthesis Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Enzymatic DNA Synthesis Market

The Enzymatic DNA Synthesis Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Enzymatic DNA Synthesis Market

The Enzymatic DNA Synthesis Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Enzymatic DNA Synthesis Market

The Enzymatic DNA Synthesis Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enzymatic DNA Synthesis Market, highlighting leading vendors and their innovative profiles. These include Ansa Biotechnologies, BioCat, Bioneer, Camena Bioscience, Codex DNA, DNA Script, Eurofins Genomics, Evonetix, Genewiz, GenScript, Integrated DNA Technologies, Kuano, Molecular Assemblies, Neuex, Nuclera, OriGene Technologies, Sigma-Aldrich, Telesis Bio, Thermo Fisher Scientific, and Twist Bioscience.

Market Segmentation & Coverage

This research report categorizes the Enzymatic DNA Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Technology
    • Liquid-Phase Synthesis
    • Microchip-Based Synthesis
    • PCR Based Enzymatic Synthesis
    • Solid-Phase Synthesis
  • Component
    • Reagents
      • Buffers
      • Enzymes
      • Nucleotides
  • Application
    • Biotechnology Research
    • Clinical Diagnostics
    • Drug Discovery
    • Therapeutics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Adoption of synthetic DNA in diagnostics and personalized medicine for better patient outcomes
5.1.1.2. Expansion of genomic data and need for rapid DNA synthesis in research and clinical settings
5.1.1.3. Strategic collaborations between key players to accelerate the development of innovative DNA synthesis solutions
5.1.1.4. Cost-effectiveness and scalability of enzymatic DNA synthesis compared to traditional methods
5.1.2. Restraints
5.1.2.1. Complexity and technical challenges in ensuring the precision and accuracy of enzymatic DNA synthesis leading to potential errors and inefficiencies
5.1.2.2. High costs associated with research and development in enzymatic DNA synthesis technology limiting accessibility and affordability
5.1.3. Opportunities
5.1.3.1. Increasing adoption of enzymatic DNA synthesis by pharmaceutical companies for drug development and screening
5.1.3.2. Innovative enzymatic DNA synthesis solutions enabling rapid prototyping of DNA constructs for synthetic biology
5.1.3.3. High-throughput enzymatic DNA synthesis technologies supporting large-scale production of custom DNA sequences
5.1.4. Challenges
5.1.4.1. Regulatory hurdles and compliance issues associated with enzymatic DNA synthesis technologies
5.1.4.2. Competition from established DNA synthesis technologies limits market penetration of enzymatic DNA synthesis
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Enzymatic DNA Synthesis Market, by Technology
6.1. Introduction
6.2. Liquid-Phase Synthesis
6.3. Microchip-Based Synthesis
6.4. PCR Based Enzymatic Synthesis
6.5. Solid-Phase Synthesis
7. Enzymatic DNA Synthesis Market, by Component
7.1. Introduction
7.2. Reagents
7.2.1. Buffers
7.2.2. Enzymes
7.2.3. Nucleotides
8. Enzymatic DNA Synthesis Market, by Application
8.1. Introduction
8.2. Biotechnology Research
8.3. Clinical Diagnostics
8.4. Drug Discovery
8.5. Therapeutics
9. Americas Enzymatic DNA Synthesis Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Enzymatic DNA Synthesis Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Enzymatic DNA Synthesis Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ENZYMATIC DNA SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ENZYMATIC DNA SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. ENZYMATIC DNA SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ENZYMATIC DNA SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ENZYMATIC DNA SYNTHESIS MARKET DYNAMICS
TABLE 7. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY MICROCHIP-BASED SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY PCR BASED ENZYMATIC SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 38. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 39. CANADA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 42. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 43. MEXICO ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 60. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 61. CHINA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 64. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 65. INDIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 72. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 73. JAPAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 96. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 97. THAILAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 109. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 110. DENMARK ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 113. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 114. EGYPT ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 117. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 118. FINLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 121. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 122. FRANCE ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 126. GERMANY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 133. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 134. ITALY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 145. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 146. NORWAY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 149. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 150. POLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 153. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 154. QATAR ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 169. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 170. SPAIN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 181. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 182. TURKEY ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM ENZYMATIC DNA SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ENZYMATIC DNA SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 192. ENZYMATIC DNA SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Enzymatic DNA Synthesis Market, which are profiled in this report, include:
  • Ansa Biotechnologies
  • BioCat
  • Bioneer
  • Camena Bioscience
  • Codex DNA
  • DNA Script
  • Eurofins Genomics
  • Evonetix
  • Genewiz
  • GenScript
  • Integrated DNA Technologies
  • Kuano
  • Molecular Assemblies
  • Neuex
  • Nuclera
  • OriGene Technologies
  • Sigma-Aldrich
  • Telesis Bio
  • Thermo Fisher Scientific
  • Twist Bioscience

Methodology

Loading
LOADING...

Table Information